Alkermes plc (ALKS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

26.60

+0.45

(+1.72%)

At close: 04:00PM EDT

26.60

0.00

(0.00%)

After hours:

04:34PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Momentum

View all chart patterns

Performance Outlook

Previous Close	26.15
Open	25.96
Bid	26.57 x 800
Ask	27.50 x 1800
Day's Range	25.96 - 26.81
52 Week Range	21.24 - 33.00
Volume	1,508,942
Avg. Volume	1,536,983

Market Cap	4.369B
Beta (5Y Monthly)	0.60
PE Ratio (TTM)	N/A
EPS (TTM)	-0.38
Earnings Date	Jul 27, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	31.78

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ALKS

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Alkermes plc
Analyst Report: Vertex Pharmaceuticals, Inc.Vertex Pharmaceuticals develops therapies to address cystic fibrosis and other diseases. The company was founded in 1989 in Cambridge, Massachusetts and has 3,500 employees. It has research programs and facilities in the U.S., the U.K., and Canada. The shares are a component of the S&P 500.
Rating
Fair Value
Economic Moat
3 days agoArgus Research